Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report

A 59-year-old Japanese woman was admitted for evaluation of muscle weakness. Autosomal dominant polycystic kidney disease had been diagnosed at the age of 47 years, followed by primary aldosteronism at 53 years. At the age of 58, tolvaptan was started (60 mg/day) to treat her renal disease. After 8...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Kyohei Kunizawa, Junichi Hoshino, Hiroki Mizuno, Tatsuya Suwabe, Keiichi Sumida, Masahiro Kawada, Masayuki Yamanouchi, Akinari Sekine, Noriko Hayami, Rikako Hiramatsu, Eiko Hasegawa, Naoki Sawa, Kenmei Takaichi, Shigeru Shibata, Yoshifumi Ubara
Format:	Artigo
Sprog:	Inglês
Udgivet:	Karger Publishers 2018-03-01
Serier:	Case Reports in Nephrology and Dialysis
Fag:	Tolvaptan Autosomal dominant polycystic kidney disease Primary aldosteronism
Online adgang:	https://www.karger.com/Article/FullText/487921
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!